# Problem Specification

> Grounding: abstract-only. All observations below are drawn from `metadata.md` / `metadata.json`; missing full-text details are marked "Not available from provided input".

## Observations

### O01: Alzheimer's disease is difficult to diagnose early
- **Statement**: Alzheimer's disease is described as a progressive neurodegenerative disorder that challenges early diagnosis and treatment.
- **Evidence**: `metadata.md` abstract, Introduction: "Alzheimer's disease is a progressive neurodegenerative disorder challenging early diagnosis and treatment."
- **Implication**: Diagnostic tools that improve early detection and treatment planning are clinically relevant.

### O02: Deep learning is being applied to multimodal brain imaging
- **Statement**: The abstract identifies recent deep learning algorithms applied to multimodal brain imaging as promising for improving diagnostic accuracy and predicting disease progression.
- **Evidence**: `metadata.md` abstract, Introduction.
- **Implication**: Multimodal neuroimaging provides a target setting where representation-learning methods may contribute to AD diagnosis.

### O03: The review searched multiple biomedical and trial databases
- **Statement**: The review process involved a comprehensive search of PubMed, Embase, Google Scholar, and ClinicalTrials.gov.
- **Evidence**: `metadata.md` abstract, Method.
- **Implication**: The paper frames its conclusions as a narrative synthesis across several literature sources rather than a single experimental study.

### O04: The abstract names three deep-learning architecture families
- **Statement**: Convolutional neural networks, recurrent neural networks, and transformer-based models are reported as architectures with potential for multimodal neuroimaging analysis.
- **Evidence**: `metadata.md` abstract, Results.
- **Implication**: The review's method space spans spatial feature extraction, sequential/temporal modeling, and attention-based architectures.

### O05: The abstract reports unresolved clinical-translation barriers
- **Statement**: Data heterogeneity, small sample sizes, limited generalizability across diverse populations, interpretability, transparency, and ethical implications are identified as significant challenges.
- **Evidence**: `metadata.md` abstract, Discussion.
- **Implication**: The review does not present deep learning as clinically solved; it positions methodological and governance constraints as central to future work.

## Gaps

### G01: Full evaluation evidence is unavailable from the provided inputs
- **Statement**: Exact study counts, effect sizes, diagnostic metrics, included-study characteristics, and evidence tables are not available from the provided metadata/abstract.
- **Caused by**: O03
- **Existing attempts**: The abstract says the authors used a best-evidence approach and critical analysis of findings.
- **Why they fail**: Not available from provided input.

### G02: Clinical translation remains constrained
- **Statement**: Even if deep learning approaches show potential, the abstract states that data heterogeneity, small sample sizes, limited generalizability, interpretability, transparency, and ethical implications remain hurdles.
- **Caused by**: O02, O05
- **Existing attempts**: Use of multimodal imaging and multiple deep-learning architecture families.
- **Why they fail**: The abstract does not provide detailed mitigation strategies; Not available from provided input.

### G03: Single-modality diagnosis is presented as less accurate than multimodal integration
- **Statement**: The abstract states that integration of multiple imaging modalities has demonstrated improved diagnostic accuracy compared to single-modality approaches.
- **Caused by**: O02, O04
- **Existing attempts**: Single-modality neuroimaging approaches.
- **Why they fail**: The abstract does not provide modality-specific comparisons or numeric performance differences; Not available from provided input.

## Key Insight

- **Insight**: A synthesis of current literature suggests that multimodal neuroimaging plus deep-learning architectures can extract Alzheimer's-relevant patterns and may improve early diagnosis, progression prediction, and biomarker discovery, while translation depends on addressing data, generalizability, interpretability, transparency, and ethics constraints.
- **Derived from**: O02, O04, O05
- **Enables**: A review-centered research agenda connecting model architectures, multimodal imaging inputs, predictive/biomarker outcomes, and clinical-translation barriers.

## Assumptions

- A1: The abstract accurately summarizes the narrative review's full-text findings.
- A2: The named databases and best-evidence approach are sufficient to characterize the review design at abstract level.
- A3: Detailed inclusion criteria, search strings, screening counts, and study-level quality ratings are not recoverable from the provided inputs.
